AzTrials
AzTrials

Acute Coronary SyndromeNCT03132935

Telemedical vs. Conventional Prehospital Care in Acute Coronary Syndromes

An observational study of Acute Coronary Syndrome, run by RWTH Aachen University at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Telemedically supported paramedic care of acute coronary syndromes was compared to a historical control period of solely conventional on-scene physician care. Quality outcomes based on current guidelines were researched als well as time requirements in both groups. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Acute Coronary Syndrome
What is being tested?
Telemedical support
Type of treatment
Surgery or procedure
How many people
221 participants
Where
1 siteGermany
Study dates
1 Jan 2014to 31 Jul 2015
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients who called the emergency medical service and the paramedics suspect acute coronary syndrome.

Who may be able to join

  • Exclusion Criteria: secondary transfers from hospital to hospital, traumatic chest pain
  • -

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Hospital Aachen

    Aachen, 52074

Other trials in Germany

About this study

Official title: Quality Outcomes in Acute Coronary Syndromes Between Telemedically Supported Paramedics and Conventional On-scene Physician Care

Telemedically supported paramedic care of acute coronary syndromes was compared to a historical control period of solely conventional on-scene physician care. Quality outcomes based on current guidelines were researched als well as time requirements in both groups.

Read the detailed description

Telemedically supported paramedic care of acute coronary syndromes was compared to a historical control period of solely conventional on-scene physician care. Quality outcomes based on current guidelines were researched als well as time requirements in both groups. All data was collected prospectively for quality management purposes and analyzed retrospectively after ethical approval by the local ethics committee.

Being tested
Telemedical support
Keywords
Non-STEMI Acute Coronary Syndrome, ST-segment elevation myocardial infarction, Telemedicine
Medical subject headings
Acute Coronary Syndrome, ST Elevation Myocardial Infarction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Telemedical supportProcedure or surgery

    Telemedical support by a physician in a telemedicine centre

Study groups in NCT03132935
Study groupRoleWhat they receive
Telemedicine groupTelemedical care of acute coronary syndromes in the prehospital phase. Paramedics were supported by a physician in a tele consultation centre.
Receives: Procedure: Telemedical support
Control groupConventional on-scene care of acute coronary syndromes by a physician. No telemedicine system was available during this control period.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Adverse events

    respiratory / circulatory insufficiency, allergic reaction, cardiac arrest

    Measured: prehospital phase (0.5-2 hours)

Secondary outcomes (7)
  1. Correct use of Aspirin

    Correct use of Aspirin based on current guidelines

    Measured: prehospital phase (0.5-2 hours)

  2. Correct use of unfractionated Heparin (UFH)

    Correct use of UFH based on current guidelines

    Measured: prehospital phase (0.5-2 hours)

  3. Correct use of Morphine

    Correct use of Morphine based on current guidelines

    Measured: prehospital phase (0.5-2 hours)

  4. Use of 12-lead-ECG

    Use of 12-lead-ECG after first medical contact

    Measured: prehospital phase (0.5-2 hours)

  5. Correct transport destination

    hospital with cath lab in ST-segment elevation myocardial infarction or high-risk Non-STEMI-ACS

    Measured: prehospital phase (0.5-2 hours)

  6. Correct use of oxygen

    Correct use of Morphine based on current guidelines

    Measured: prehospital phase (0.5-2 hours)

  7. Correct use of Glyceroltrinitrate

    Correct use of Glyceroltrinitrate based on current guidelines

    Measured: prehospital phase (0.5-2 hours)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Apr 2017
  2. Study start1 Jan 2014
  3. Primary completion31 Jul 2015
  4. Study completion31 Jul 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
221 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03132935
Sponsor's protocol ID
TEMS-ACS
Status last verified
Apr 2017
First submitted
24 Apr 2017
Last updated
28 Apr 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Acute Coronary Syndrome, run by RWTH Aachen University at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Apr 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Adverse events (time frame: prehospital phase (0.5-2 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Apr 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in